Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jun;65(6):2080–2087. doi: 10.1128/iai.65.6.2080-2087.1997

Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus.

Y Ji 1, B Carlson 1, A Kondagunta 1, P P Cleary 1
PMCID: PMC175287  PMID: 9169735

Abstract

Early inflammatory events are initiated by phased production of C5a and interleukin-8 in tissue. Most serotypes of group A streptococci express a surface-bound peptidase (SCPA) which specifically cleaves mouse and human C5a chemotaxins. This study investigates the impact of SCPA on colonization of the nasopharyngeal mucosa of mice and evaluates its potential to induce protective immunity. Two strains, serotypes M6 and M49, which contain insertion and deletion mutations in the SCPA gene (scpA) and represent the two major subdivisions of group A streptococci, were characterized and compared in a mouse intranasal infection model. In this model, SCPA mutants were more rapidly cleared from the nasopharynges of inoculated mice compared with wild-type strains. A 2,908-bp fragment of scpA49 gene, obtained by PCR, was ligated to the expression vector pGEX-4T-1 and expressed in Escherichia coli. The affinity-purified deltaSCPA49 protein proved to be highly immunogenic in mice and rabbits. Although the purified deltaSCPA49 immunogen lacked enzymatic activity, it induced high titers of rabbit antibodies which were able to neutralize peptidase activity associated with M1, M6, M12, and M49 streptococci in vitro. This result confirmed that antipeptidase antibodies lack serotype specificity. Intranasal immunization of mice with the deleted form of the SCPA49 protein stimulated significant levels of specific salivary secretory immunoglobulin A (IgA) and serum IgG antibodies and reduced the potential of wild-type M1, M2, M6, M11, and M49 streptococci to colonize. These experiments suggest a new approach to vaccine development for prevention of streptococcal pharyngitis.

Full Text

The Full Text of this article is available as a PDF (711.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bessen D. E., Sotir C. M., Readdy T. L., Hollingshead S. K. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis. 1996 Apr;173(4):896–900. doi: 10.1093/infdis/173.4.896. [DOI] [PubMed] [Google Scholar]
  2. Bessen D., Fischetti V. A. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun. 1988 Oct;56(10):2666–2672. doi: 10.1128/iai.56.10.2666-2672.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Booth S. A., Moody C. E., Dahl M. V., Herron M. J., Nelson R. D. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992 Feb;98(2):135–140. doi: 10.1111/1523-1747.ep12555654. [DOI] [PubMed] [Google Scholar]
  4. Bronze M. S., Courtney H. S., Dale J. B. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol. 1992 Feb 1;148(3):888–893. [PubMed] [Google Scholar]
  5. Chen C. C., Cleary P. P. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem. 1990 Feb 25;265(6):3161–3167. [PubMed] [Google Scholar]
  6. Chmouryguina I., Suvorov A., Ferrieri P., Cleary P. P. Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun. 1996 Jul;64(7):2387–2390. doi: 10.1128/iai.64.7.2387-2390.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cleary P. P., Handley J., Suvorov A. N., Podbielski A., Ferrieri P. Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun. 1992 Oct;60(10):4239–4244. doi: 10.1128/iai.60.10.4239-4244.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cleary P. P., Prahbu U., Dale J. B., Wexler D. E., Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun. 1992 Dec;60(12):5219–5223. doi: 10.1128/iai.60.12.5219-5223.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Courtney H. S., Bronze M. S., Dale J. B., Hasty D. L. Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect Immun. 1994 Nov;62(11):4868–4873. doi: 10.1128/iai.62.11.4868-4873.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cunningham M. W., Hall N. K., Krisher K. K., Spanier A. M. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol. 1986 Jan;136(1):293–298. [PubMed] [Google Scholar]
  11. Fischetti V. A. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989 Jul;2(3):285–314. doi: 10.1128/cmr.2.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gemmell C. G., Peterson P. K., Regelman W., Schmeling D., Hoidal J. R., Quie P. G. Phagocytosis and killing of Streptococcus pyogenes by human alveolar macrophages. Infect Immun. 1981 Jun;32(3):1298–1300. doi: 10.1128/iai.32.3.1298-1300.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haanes E. J., Heath D. G., Cleary P. P. Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol. 1992 Aug;174(15):4967–4976. doi: 10.1128/jb.174.15.4967-4976.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hollingshead S. K., Readdy T. L., Yung D. L., Bessen D. E. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol Microbiol. 1993 May;8(4):707–717. doi: 10.1111/j.1365-2958.1993.tb01614.x. [DOI] [PubMed] [Google Scholar]
  15. Hollingshead S. K., Simecka J. W., Michalek S. M. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect Immun. 1993 Jun;61(6):2277–2283. doi: 10.1128/iai.61.6.2277-2283.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ivey C. L., Williams F. M., Collins P. D., Jose P. J., Williams T. J. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest. 1995 Jun;95(6):2720–2728. doi: 10.1172/JCI117974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ji Y., McLandsborough L., Kondagunta A., Cleary P. P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun. 1996 Feb;64(2):503–510. doi: 10.1128/iai.64.2.503-510.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. O'Connor S. P., Darip D., Fraley K., Nelson C. M., Kaplan E. L., Cleary P. P. The human antibody response to streptococcal C5a peptidase. J Infect Dis. 1991 Jan;163(1):109–116. doi: 10.1093/infdis/163.1.109. [DOI] [PubMed] [Google Scholar]
  20. Podbielski A., Flosdorff A., Weber-Heynemann J. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect Immun. 1995 Jan;63(1):9–20. doi: 10.1128/iai.63.1.9-20.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Podbielski A., Schnitzler N., Beyhs P., Boyle M. D. M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol. 1996 Feb;19(3):429–441. doi: 10.1046/j.1365-2958.1996.377910.x. [DOI] [PubMed] [Google Scholar]
  22. Raeder R., Boyle M. D. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis. 1996 Apr;173(4):888–895. doi: 10.1093/infdis/173.4.888. [DOI] [PubMed] [Google Scholar]
  23. Simpson W. J., LaPenta D., Chen C., Cleary P. P. Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol. 1990 Feb;172(2):696–700. doi: 10.1128/jb.172.2.696-700.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wessels M. R., Goldberg J. B., Moses A. E., DiCesare T. J. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun. 1994 Feb;62(2):433–441. doi: 10.1128/iai.62.2.433-441.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wexler D. E., Chenoweth D. E., Cleary P. P. Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8144–8148. doi: 10.1073/pnas.82.23.8144. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES